Stocks and Investing
Stocks and Investing
Tue, April 12, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (AMGN) at Hold with Decreased Target to $237 on, Apr 12th, 2022
Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $238 to $237 on, Apr 12th, 2022.
Matthew has made no other calls on AMGN in the last 4 months.
There are 4 other peers that have a rating on AMGN. Out of the 4 peers that are also analyzing AMGN, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $250 on, Wednesday, February 9th, 2022
- Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $255 on, Wednesday, January 5th, 2022
- Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $218 on, Tuesday, December 21st, 2021
This is the rating of the analyst that currently disagrees with Matthew
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $285 on, Wednesday, February 9th, 2022
Contributing Sources